BCX-17725

N/A

Report date: 2026/03/07 20:00:27

Base Information

Drug NameBCX-17725
Drug Alias NameBCX17725BCX-17725
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionKallikrein-5 inhibitors
TargetsKallikrein-5
Therapy Area/IndicationsNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustralia +[5
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A